75 related articles for article (PubMed ID: 9367887)
41. Differential nigral expression of bcl-2 protein family in the pure and common forms of Dementia with Lewy bodies: relevance for dopaminergic neuronal vulnerability.
Saldaña M; Aguilar E; Bonastre M; Marin C
J Neural Transm (Vienna); 2007; 114(11):1469-77. PubMed ID: 17641817
[TBL] [Abstract][Full Text] [Related]
42. Expression of Bcl-2, Bax and Caspase-3 in nerve tissues of rats chronically exposed to 2,5-hexanedione.
Cui N; Li S; Zhao X; Zhang T; Zhang C; Yu L; Zhu Z; Xie K
Neurochem Res; 2007 Sep; 32(9):1566-72. PubMed ID: 17492505
[TBL] [Abstract][Full Text] [Related]
43. Cellular and molecular mechanisms of Parkinson's disease: neurotoxins, causative genes, and inflammatory cytokines.
Nagatsu T; Sawada M
Cell Mol Neurobiol; 2006; 26(4-6):781-802. PubMed ID: 16823625
[TBL] [Abstract][Full Text] [Related]
44. Review of apoptosis vs. necrosis of substantia nigra pars compacta in Parkinson's disease.
Kostrzewa RM
Neurotox Res; 2000; 2(2-3):239-50. PubMed ID: 16787844
[TBL] [Abstract][Full Text] [Related]
45. Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?
Blandini F
CNS Drug Rev; 2005; 11(2):183-94. PubMed ID: 16007239
[TBL] [Abstract][Full Text] [Related]
46. The retina as a novel in vivo model for studying the role of molecules of the Bcl-2 family in relation to MPTP neurotoxicity.
Chen ST; Hsu JR; Hsu PC; Chuang JI
Neurochem Res; 2003 Jun; 28(6):805-14. PubMed ID: 12718432
[TBL] [Abstract][Full Text] [Related]
47. Cell death mechanisms in neurodegeneration.
Jellinger KA
J Cell Mol Med; 2001; 5(1):1-17. PubMed ID: 12067447
[TBL] [Abstract][Full Text] [Related]
48. Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum.
Fatemi SH; Stary JM; Halt AR; Realmuto GR
J Autism Dev Disord; 2001 Dec; 31(6):529-35. PubMed ID: 11814262
[TBL] [Abstract][Full Text] [Related]
49. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.
Halliwell B
Drugs Aging; 2001; 18(9):685-716. PubMed ID: 11599635
[TBL] [Abstract][Full Text] [Related]
50. Neurodegeneration in normal brain aging and disease.
Thal DR; Del Tredici K; Braak H
Sci Aging Knowledge Environ; 2004 Jun; 2004(23):pe26. PubMed ID: 15190177
[TBL] [Abstract][Full Text] [Related]
51. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia.
Trojanowski JQ; Goedert M; Iwatsubo T; Lee VM
Cell Death Differ; 1998 Oct; 5(10):832-7. PubMed ID: 10203692
[TBL] [Abstract][Full Text] [Related]
52. Upregulation of the anti-apoptotic protein Bcl-2 may be an early event in neurodegeneration: studies on Parkinson's and incidental Lewy body disease.
Marshall KA; Daniel SE; Cairns N; Jenner P; Halliwell B
Biochem Biophys Res Commun; 1997 Nov; 240(1):84-7. PubMed ID: 9367887
[TBL] [Abstract][Full Text] [Related]
53. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.
Dickson DW; Fujishiro H; DelleDonne A; Menke J; Ahmed Z; Klos KJ; Josephs KA; Frigerio R; Burnett M; Parisi JE; Ahlskog JE
Acta Neuropathol; 2008 Apr; 115(4):437-44. PubMed ID: 18264713
[TBL] [Abstract][Full Text] [Related]
54. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
55. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease.
Dexter DT; Sian J; Rose S; Hindmarsh JG; Mann VM; Cooper JM; Wells FR; Daniel SE; Lees AJ; Schapira AH
Ann Neurol; 1994 Jan; 35(1):38-44. PubMed ID: 8285590
[TBL] [Abstract][Full Text] [Related]
56. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
